{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:53:10Z","timestamp":1788544390385,"version":"build-2803163510"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mad.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T11:04:57Z","timestamp":1557572697000},"page":"7-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Crucial players in Alzheimer\u2019s disease and diabetes mellitus: Friends or foes?"],"prefix":"10.1016","volume":"181","author":[{"given":"AM.","family":"Kubis-Kubiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rorbach-Dolata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Piwowar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2019.03.008_bib0005","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","article-title":"Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study","volume":"75","author":"Ahtiluoto","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2019.03.008_bib0010","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","author":"An","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.mad.2019.03.008_bib0015","article-title":"Stronger relationship of serum apolipoprotein A-1 and B with diabetic retinopathy than traditional lipids","author":"Ankit","year":"2016","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.mad.2019.03.008_bib0020","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/sj.emboj.7600415","article-title":"RAGE potentiates A\u03b2-induced perturbation of neuronal function in transgenic mice","volume":"23","author":"Arancio","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.mad.2019.03.008_bib0025","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M112.446070","article-title":"Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease","volume":"288","author":"Basurto-Islas","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mad.2019.03.008_bib0030","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.7b00410","article-title":"Advanced glycation end products modulate amyloidogenic APP processing and tau phosphorylation: a mechanistic link between glycation and the development of alzheimer\u2019s disease","author":"Batkulwar","year":"2018","journal-title":"ACS Chem. Neurosci. acschemneuro"},{"key":"10.1016\/j.mad.2019.03.008_bib0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/gerona\/60.4.471","article-title":"Type 2 diabetes is negatively associated with Alzheimer\u2019s disease neuropathology","volume":"60","author":"Beeri","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.mad.2019.03.008_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/glia.20557","article-title":"Astrocyte glycogen and brain energy metabolism","author":"Brown","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.mad.2019.03.008_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2010.08.048","article-title":"Cerebral cortical thickness in patients with type 2 diabetes","author":"Brundel","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mad.2019.03.008_bib0050","first-page":"7","article-title":"Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer\u2019s disease","author":"Byun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2019.03.008_bib0055","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in alzheimer\u2019s disease","author":"Cai","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.mad.2019.03.008_bib0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archneurol.2008.1","article-title":"Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment","volume":"65","author":"Caselli","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mad.2019.03.008_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/cns.12503","article-title":"Hyperglycemia increases the production of amyloid beta-peptide leading to decreased endothelial tight junction","volume":"22","author":"Chao","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.mad.2019.03.008_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits","author":"Chatterjee","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0075","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-013-8539-y","article-title":"Intracerebroventricular streptozotocin exacerbates alzheimer-like changes of 3xTg-AD mice","author":"Chen","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mad.2019.03.008_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","article-title":"Antidiabetic drugs restore abnormal transport of amyloid-\u03b2 across the blood-brain barrier and memory impairment in db\/db mice","volume":"101","author":"Chen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mad.2019.03.008_bib0085","first-page":"1","article-title":"RAGE-NF-\u03baB-PPAR\u03b3 signaling is involved in AGEs-Induced upregulation of Amyloid-\u03b2 influx transport in an in vitro BBB model","author":"Chen","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0090","article-title":"[Endocrine disruptors: a missing link in the pandemy of type 2 diabetes and obesity?]","author":"Chevalier","year":"2016","journal-title":"Obesite, diabete type 2 perturbateurs endocriniens"},{"key":"10.1016\/j.mad.2019.03.008_bib0095","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1096\/fj.08-126383","article-title":"RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer\u2019s disease animal model","volume":"23","author":"Cho","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.mad.2019.03.008_bib0100","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/emm.2013.147","article-title":"Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"46","author":"Choi","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mad.2019.03.008_bib0105","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/db06-0485","article-title":"Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency","volume":"55","author":"Clodfelder-Miller","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2005.09.018","article-title":"Links between cognitive impairment in insulin resistance: an explanatory model","author":"Convit","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2019.03.008_bib0115","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mad.2019.03.008_bib0120","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer\u2019s-linked toxins: insulin signaling prevents the pathogenic binding of A\u03b2 oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0125","first-page":"1049","article-title":"Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis","volume":"10","author":"de la Monte","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.mad.2019.03.008_bib0130","first-page":"1","article-title":"Type 2 diabetes mellitus","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Prim"},{"key":"10.1016\/j.mad.2019.03.008_bib0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI5656","article-title":"Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes","volume":"105","author":"Devedjian","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mad.2019.03.008_bib0140","first-page":"7","article-title":"Mechanisms underlying insulin deficiency-induced acceleration of \u03b2-amyloidosis in a mouse model of Alzheimer\u2019s disease","author":"Devi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2019.03.008_bib0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0736-5748(94)90053-1","article-title":"Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats","volume":"12","author":"Duelli","year":"1994","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0150","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1212\/01.WNL.0000161871.83614.BB","article-title":"Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects","volume":"64","author":"Enzinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2019.03.008_bib0155","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.crvi.2017.07.003","article-title":"Environmental endocrine disruptors: New diabetogens?","author":"F\u00e9nichel","year":"2017","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"10.1016\/j.mad.2019.03.008_bib0165","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3389\/fnins.2018.00830","article-title":"Insulin resistance in Alzheimer\u2019s disease","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0170","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-008-9104-2","article-title":"Mechanisms of disease: the oxidative stress theory of diabetic neuropathy","author":"Figueroa-Romero","year":"2008","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.mad.2019.03.008_bib0175","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2061376","article-title":"Metabolic derangements contribute to reduced sRAGE isoforms in subjects with Alzheimer\u2019s disease","author":"Fuller","year":"2018","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.mad.2019.03.008_bib0180","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/revneuro-2013-0034","article-title":"New animal models of Alzheimer\u2019s disease that display insulin desensitization in the brain","volume":"24","author":"Gao","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0190","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0195","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-008-0069-9","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment","author":"Ghidoni","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mad.2019.03.008_bib0200","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2006-9101","article-title":"Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation","author":"Gong","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2006.04368.x","article-title":"Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein","volume":"101","author":"Gr\u00fcnblatt","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2019.03.008_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.05.026","article-title":"AGEs\/RAGE complex upregulates BACE1 via NF-\u03baB pathway activation","volume":"33","author":"Guglielmotto","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2019.03.008_bib0215","first-page":"6","article-title":"Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mad.2019.03.008_bib0220","first-page":"454","article-title":"Plasma levels of soluble receptor for advanced glycation end products in Alzheimer\u2019s disease","volume":"127","author":"He","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","author":"Heindel","year":"2017","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.mad.2019.03.008_bib0230","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.49.5.1306","article-title":"Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects: a retrospective postmortem immunocytochemical and histofluorescent study","volume":"49","author":"Heitner","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2019.03.008_bib0235","doi-asserted-by":"crossref","DOI":"10.1586\/ern.10.136","article-title":"Cerebral glucose metabolism in preclinical and prodromal Alzheimers disease","author":"Herholz","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.mad.2019.03.008_bib0240","doi-asserted-by":"crossref","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","article-title":"Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons","volume":"272","author":"Hong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mad.2019.03.008_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02251132","article-title":"Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases","volume":"3","author":"Hoyer","year":"1991","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.mad.2019.03.008_bib0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pscychresns.2006.12.003","article-title":"Reduced cerebral glucose metabolism in patients at risk for Alzheimer\u2019s disease","volume":"155","author":"Hunt","year":"2007","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.mad.2019.03.008_bib0255","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-010-0122-6","article-title":"Hormonal influences on cognition and risk for Alzheimer\u2019s disease","author":"Janicki","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.mad.2019.03.008_bib0260","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0265","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jnr.21787","article-title":"Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer\u2019s disease and correction by insulin","volume":"86","author":"Jolivalt","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0270","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2009.11.005","article-title":"Type 1 diabetes exaggerates features of Alzheimer\u2019s disease in APP transgenic mice","volume":"223","author":"Jolivalt","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mad.2019.03.008_bib0275","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is alzheimer\u2019s disease a type 3 diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mad.2019.03.008_bib0280","first-page":"4","article-title":"Experimental diabetes mellitus exacerbates Tau pathology in a transgenic mouse model of Alzheimer\u2019s disease","author":"Ke","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2019.03.008_bib0285","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.3","article-title":"Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome","author":"Kim","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mad.2019.03.008_bib0290","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","article-title":"Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mad.2019.03.008_bib0295","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2010-1332","article-title":"A relationship between alzheimer\u2019s disease and type 2 diabetes mellitus through the measurement of serum amyloid-\u03b2 autoantibodies","author":"Kim","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0300","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3233\/JAD-121669","article-title":"Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and alzheimer\u2019s disease","volume":"34","author":"Kim","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040503","article-title":"Diabetes mellitus induces Alzheimer\u2019s disease pathology: histopathological evidence from animal models","author":"Kimura","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mad.2019.03.008_bib0310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/01616412.2017.1281195","article-title":"Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer\u2019s disease","volume":"39","author":"Kitamura","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0315","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","author":"Kleinridders","year":"2014","journal-title":"Diabetes."},{"key":"10.1016\/j.mad.2019.03.008_bib0320","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","article-title":"The aggregation potential of human amylin determines its cytotoxicity towards islet \u03b2-cells","volume":"273","author":"Konarkowska","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.mad.2019.03.008_bib0325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2009-1011","article-title":"Risk of incident Alzheimer\u2019s disease in diabetic patients: a systematic review of prospective trials","volume":"16","author":"Kopf","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0330","article-title":"Brain-derived neurotrophic factor (BDNF) and type 2 diabetes","author":"Krabbe","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.mad.2019.03.008_bib0335","first-page":"373","article-title":"The relationship between Alzheimer\u2019s disease and diabetes: type 3 diabetes?","volume":"14","author":"Kroner","year":"2009","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.mad.2019.03.008_bib0340","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/diab.44.12.1399","article-title":"Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia","volume":"44","author":"Kumagai","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0345","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in alzheimer\u2019s disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0350","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archneurol.2010.30","article-title":"Hypometabolism in Alzheimer-affected brain regions in cognitively healthy latino individuals carrying the apolipoprotein E \u03b54 allele","volume":"67","author":"Langbaum","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mad.2019.03.008_bib0355","doi-asserted-by":"crossref","DOI":"10.2337\/db12-0866","article-title":"Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice","author":"Leboucher","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0360","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.mad.2019.03.008_bib0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","article-title":"Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer\u2019s disease","volume":"9","author":"Lester-Coll","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"80","key":"10.1016\/j.mad.2019.03.008_bib0370","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.mad.2019.03.008_bib0375","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/db07-0171","article-title":"Alzheimer-like changes in rat models of spontaneous diabetes","volume":"56","author":"Li","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0380","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/syn.20644","article-title":"Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice","volume":"63","author":"Li","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.mad.2019.03.008_bib0385","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-009-0334-6","article-title":"Association between the RAGE G82S polymorphism and Alzheimer\u2019s disease","author":"Li","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mad.2019.03.008_bib0390","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2019.03.008_bib0395","article-title":"Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer\u2019s disease biomarker amyloid \u03b21-42 in Alzheimer\u2019s disease neuroimaging initiative participants","author":"Li","year":"2018","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.mad.2019.03.008_bib0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2012.06.005","article-title":"Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer\u2019s disease","author":"Liang","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0405","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","article-title":"Human but not rat amylin shares neurotoxic properties with A\u03b242 in long-term hippocampal and cortical cultures","volume":"582","author":"Lim","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mad.2019.03.008_bib0410","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1046\/j.1432-1327.2000.01452.x","article-title":"Transition metal-mediated glycoxidation accelerates cross-linking of \u03b2- amyloid peptide","volume":"267","author":"Loske","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mad.2019.03.008_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2014.08.008","article-title":"The mitochondrial O-linked N-acetylglucosamine transferase (mOGT) in the diabetic patient could be the initial trigger to develop Alzheimer disease","author":"Lozano","year":"2014","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.mad.2019.03.008_bib0420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.npep.2017.04.001","article-title":"Effect of amyloid-B (25\u201335) in hyperglycemic and hyperinsulinemic rats, effects on phosphorylation and O-GlcNAcylation of tau protein","volume":"63","author":"Lozano","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mad.2019.03.008_bib0425","article-title":"Changes in cerebrospinal fluid tau and \u03b2-amyloid levels in diabetic and prediabetic patients: a meta-analysis","author":"Lu","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0430","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12436","article-title":"High dietary advanced glycation end products are associated with poorer spatial learning and accelerated A\u03b2 deposition in an Alzheimer mouse model","volume":"15","author":"Lubitz","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.mad.2019.03.008_bib0435","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","article-title":"Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer\u2019s disease: identification of a cellular activation mechanism","volume":"171","author":"Lue","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mad.2019.03.008_bib0440","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1172\/JCI79742","article-title":"Hyperglycemia modulates extracellular amyloid-\u03b2 concentrations and neuronal activity in vivo","volume":"125","author":"Macauley","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mad.2019.03.008_bib0445","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: implications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.mad.2019.03.008_bib0450","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study","volume":"75","author":"Matsuzaki","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2019.03.008_bib0455","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-160891","article-title":"Autotaxin is related to metabolic dysfunction and predicts Alzheimer\u2019s disease outcomes","author":"McLimans","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0460","doi-asserted-by":"crossref","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","article-title":"Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP","volume":"291","author":"Meier","year":"2006","journal-title":"AJP Endocrinol. Metab."},{"key":"10.1016\/j.mad.2019.03.008_bib0465","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2002-4203","article-title":"Serum pentosidine as an indicator of Alzheimer\u2019s disease","volume":"4","author":"Meli","year":"2002","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0470","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer\u2019s disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0475","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00146.2017","article-title":"Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes","author":"Miranda","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"80","key":"10.1016\/j.mad.2019.03.008_bib0480","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.6779377","article-title":"Nonenzymatic browning in vivo: possible process for aging of long-lived proteins","volume":"211","author":"Monnier","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.mad.2019.03.008_bib0485","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001982","article-title":"Type 2 diabetes mellitus and biomarkers of neurodegeneration","author":"Moran","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2019.03.008_bib0490","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease","author":"Mosconi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mad.2019.03.008_bib0495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-7091-0643-3_4","article-title":"Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer\u2019s disease","author":"Munch","year":"2003","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.mad.2019.03.008_bib0500","first-page":"874","article-title":"Glycation, glycolysis, and neurodegenerative diseases: Is there any connection?","volume":"82","author":"Muronetz","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.mad.2019.03.008_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2009.02.016","article-title":"The pancreatic \u03b2-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes","author":"Nadal","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mad.2019.03.008_bib0510","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.690","article-title":"Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease","author":"Nakamura","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.mad.2019.03.008_bib0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2014.10.006","article-title":"Environment, epigenetics and neurodegeneration: focus on nutrition in Alzheimer\u2019s disease","author":"Nicolia","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.mad.2019.03.008_bib0520","article-title":"Chronic arsenic exposure increases a\u03b2(1-42) production and receptor for advanced glycation end products expression in rat brain","author":"Nino","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.mad.2019.03.008_bib0525","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1523\/JNEUROSCI.0204-08.2008","article-title":"Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction","volume":"28","author":"Origlia","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0530","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2019.03.008_bib0535","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1210\/en.2012-1661","article-title":"Insulin has multiple antiamyloidogenic effects on human neuronal cells","volume":"154","author":"Pandini","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.mad.2019.03.008_bib0540","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology","author":"Pappolla","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.mad.2019.03.008_bib0545","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2337\/diab.39.9.1040","article-title":"Downregulation of blood-brain barrier glucose transporter in experimental diabetes","volume":"39","author":"Pardridge","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0550","doi-asserted-by":"crossref","DOI":"10.1080\/10408398.2015.1126547","article-title":"Risks and benefits related to alimentary exposure to xenoestrogens","author":"Paterni","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.mad.2019.03.008_bib0555","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.lfs.2006.07.018","article-title":"Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats","volume":"79","author":"Pathan","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.mad.2019.03.008_bib0560","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1159\/000356579","article-title":"Hyperphosphorylation of tau protein in hippocampus of central insulin-resistant rats is associated with cognitive impairment","volume":"32","author":"Peng","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.mad.2019.03.008_bib0565","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbadis.2012.09.011","article-title":"Lysosomal enzymes are decreased in the kidney of diabetic rats","volume":"1832","author":"Peres","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0570","first-page":"201","article-title":"Animal model of insulin-resistant brain state: intracerebroventricular streptozotocin injection deteriorates Alzheimer-like changes in Tg2576 APP-overexpressing mice","volume":"1","author":"Plaschke","year":"2011","journal-title":"Adv. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0575","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2337\/db08-1565","article-title":"Hyperglycemia impairs proteasome function by methylglyoxal","volume":"59","author":"Queisser","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0580","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuropharm.2014.08.013","article-title":"Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin","volume":"86","author":"Rajasekar","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mad.2019.03.008_bib0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2007.03.034","article-title":"Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus","author":"Rao","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mad.2019.03.008_bib0590","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2012-120106","article-title":"Changes in glycemic control are associated with changes in cognition in non-diabetic elderly","volume":"30","author":"Ravona-Springer","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0595","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3233\/JAD-132060","article-title":"Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction","volume":"40","author":"Reddy","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0600","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0605","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12534","article-title":"Insulin signalling in Alzheimer\u2032s disease and diabetes: from epidemiology to molecular links","author":"Ribe","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mad.2019.03.008_bib0610","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mad.2019.03.008_bib0615","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00125-009-1393-9","article-title":"Glucose metabolism and the risk of Alzheimer\u2019s disease and dementia: a population-based 12 year follow-up study in 71-year-old men","volume":"52","author":"R\u00f6nnemaa","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.mad.2019.03.008_bib0620","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","article-title":"Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels","volume":"12","author":"Ruiz","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.mad.2019.03.008_bib0625","article-title":"Diabetes and alzheimer\u2019s disease: a link not as simple as it seems","author":"Salas","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0630","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-328X(02)00487-4","article-title":"Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain","volume":"107","author":"Sankar","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0635","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(00)03075-4","article-title":"Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer\u2019s disease","volume":"888","author":"Sasaki","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0640","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2011\/306905","article-title":"Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset alzheimer\u2019s disease","volume":"2011","author":"Schuh","year":"2011","journal-title":"ISRN Neurol."},{"key":"10.1016\/j.mad.2019.03.008_bib0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2016.05.017","article-title":"A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer\u2019s disease severity","author":"Schwarz","year":"2016","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.mad.2019.03.008_bib0655","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2337\/diabetes.50.10.2203","article-title":"The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose Transport\/Metabolism in humans","volume":"50","author":"Seaquist","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.mad.2019.03.008_bib0660","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(89)90093-7","article-title":"Amyloid \u03b2 protein precursor and the pathogenesis of Alzheimer\u2019s disease","author":"Selkoe","year":"1989","journal-title":"Cell."},{"key":"10.1016\/j.mad.2019.03.008_bib0665","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0024-3205(00)01005-5","article-title":"Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment","volume":"68","author":"Sharma","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.mad.2019.03.008_bib0670","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bst0290513","article-title":"Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors","volume":"29","author":"Siddle","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.mad.2019.03.008_bib0675","doi-asserted-by":"crossref","DOI":"10.2741\/3496","article-title":"Identification of autoantibody against beta-amyloid peptide in the serum of elderly","author":"Sohn","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0680","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archneurol.2008.579","article-title":"Different patterns of cerebral injury in dementia with or without diabetes","volume":"66","author":"Sonnen","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mad.2019.03.008_bib0685","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease--is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0690","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0031-9384(04)00348-8","article-title":"Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans","volume":"83","author":"Stockhorst","year":"2004","journal-title":"Physiol. Behav."},{"issue":"80","key":"10.1016\/j.mad.2019.03.008_bib0695","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s diseases","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.mad.2019.03.008_bib0700","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2011-110776","article-title":"Endogenous secretory receptor for advanced glycation end-products inhibits amyloid-\u03b21-42 uptake into mouse brain","author":"Sugihara","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2006.02.012","article-title":"Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus","author":"Suwa","year":"2006","journal-title":"Metabolism."},{"key":"10.1016\/j.mad.2019.03.008_bib0710","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0715","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.mehy.2004.03.005","article-title":"Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo","volume":"63","author":"Takeuchi","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mad.2019.03.008_bib0720","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/138161208784139693","article-title":"Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of alzheimers disease","volume":"14","author":"Takeuchi","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mad.2019.03.008_bib0725","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnen\/59.12.1094","article-title":"Neurotoxicity of advanced glycation end-products for cultured cortical neurons","volume":"59","author":"Takeuchi","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mad.2019.03.008_bib0730","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mad.2019.03.008_bib0735","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-006-0394-1","article-title":"Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes","author":"Tan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.mad.2019.03.008_bib0740","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","article-title":"A\u03b2 inhibits the proteasome and enhances amyloid and tau accumulation","volume":"29","author":"Tseng","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2019.03.008_bib0745","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2009.09.008","article-title":"Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer\u2019s disease and diabetes mellitus","volume":"37","author":"Valente","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2006.06.003","article-title":"Insulin signaling in the central nervous system: learning to survive","author":"van der Heide","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mad.2019.03.008_bib0755","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0760","doi-asserted-by":"crossref","DOI":"10.1111\/j.1472-8206.2009.00739.x","article-title":"Lipid modification in type 2 diabetes: the role of LDL and HDL","author":"Verg\u00e8s","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.mad.2019.03.008_bib0765","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0770","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jnc.13122","article-title":"A\u03b21-42oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins","volume":"134","author":"Wan","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2019.03.008_bib0775","first-page":"293","article-title":"Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women","volume":"10","author":"Yaffe","year":"2006","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.mad.2019.03.008_bib0780","doi-asserted-by":"crossref","DOI":"10.2741\/e178","article-title":"Soluble form of a receptor for advanced glycation end products sRAGE as a biomarker","author":"Yamagishi","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0785","first-page":"129","article-title":"Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy","volume":"23","author":"Yamagishi","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.mad.2019.03.008_bib0790","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1073\/pnas.91.16.7787","article-title":"Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress","volume":"91","author":"Yan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mad.2019.03.008_bib0795","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.mad.2019.03.008_bib0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2013.07.009","article-title":"Molecular links between Alzheimer\u2019s disease and diabetes mellitus","author":"Yang","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.mad.2019.03.008_bib0805","first-page":"8","article-title":"High glucose promotes a\u03b2 production by inhibiting APP degradation","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2019.03.008_bib0810","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0361-9230(00)00274-4","article-title":"Increase in vulnerability of middle-aged rat brain to lead by cerebral energy depletion","volume":"52","author":"Yun","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mad.2019.03.008_bib0815","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","article-title":"Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer\u2019s disease intervention","volume":"24","author":"Zhao","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2019.03.008_bib0820","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.mad.2019.03.008_bib0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2009.12.010","article-title":"17\u03b2-Estradiol regulates insulin-degrading enzyme expression via an ER\u03b2\/PI3-K pathway in hippocampus: relevance to Alzheimer\u2019s prevention","author":"Zhao","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2019.03.008_bib0830","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-122341","article-title":"Early intervention with an estrogen receptor \u03b2-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer\u2019s disease","author":"Zhao","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2019.03.008_bib0835","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-012-2942-3","article-title":"Low BDNF is associated with cognitive deficits in patients with type 2 diabetes","author":"Zhen","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.mad.2019.03.008_bib0840","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637418302124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637418302124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:39:40Z","timestamp":1758649180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637418302124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":168,"alternative-id":["S0047637418302124"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2019.03.008","relation":{},"ISSN":["0047-6374"],"issn-type":[{"value":"0047-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crucial players in Alzheimer\u2019s disease and diabetes mellitus: Friends or foes?","name":"articletitle","label":"Article Title"},{"value":"Mechanisms of Ageing and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mad.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}